291 related articles for article (PubMed ID: 11485919)
1. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells.
Yiu GK; Chan WY; Ng SW; Chan PS; Cheung KK; Berkowitz RS; Mok SC
Am J Pathol; 2001 Aug; 159(2):609-22. PubMed ID: 11485919
[TBL] [Abstract][Full Text] [Related]
2. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
[TBL] [Abstract][Full Text] [Related]
3. Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer.
Said N; Najwer I; Motamed K
Am J Pathol; 2007 Mar; 170(3):1054-63. PubMed ID: 17322388
[TBL] [Abstract][Full Text] [Related]
4. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.
Mok SC; Chan WY; Wong KK; Muto MG; Berkowitz RS
Oncogene; 1996 May; 12(9):1895-901. PubMed ID: 8649850
[TBL] [Abstract][Full Text] [Related]
5. Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer.
Paley PJ; Goff BA; Gown AM; Greer BE; Sage EH
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):336-41. PubMed ID: 10985890
[TBL] [Abstract][Full Text] [Related]
6. Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis.
Said N; Motamed K
Am J Pathol; 2005 Dec; 167(6):1739-52. PubMed ID: 16314484
[TBL] [Abstract][Full Text] [Related]
7. SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer.
Chen J; Wang M; Xi B; Xue J; He D; Zhang J; Zhao Y
PLoS One; 2012; 7(8):e42413. PubMed ID: 22879971
[TBL] [Abstract][Full Text] [Related]
8. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
[TBL] [Abstract][Full Text] [Related]
9. SPARC, a matricellular glycoprotein with important biological functions.
Yan Q; Sage EH
J Histochem Cytochem; 1999 Dec; 47(12):1495-506. PubMed ID: 10567433
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells.
Atorrasagasti C; Malvicini M; Aquino JB; Alaniz L; Garcia M; Bolontrade M; Rizzo M; Podhajcer OL; Mazzolini G
Int J Cancer; 2010 Jun; 126(11):2726-40. PubMed ID: 19830689
[TBL] [Abstract][Full Text] [Related]
11. SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk.
Said NA; Najwer I; Socha MJ; Fulton DJ; Mok SC; Motamed K
Neoplasia; 2007 Jan; 9(1):23-35. PubMed ID: 17325741
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of SPARC and its impact on proliferation and apoptosis in ADPKD cyst-lining epithelia.
Wang W; Mei C; Tang B; Zhao H; Xu C; Li Z; Shen X; Fu W; Dai B
Nephrol Dial Transplant; 2006 May; 21(5):1278-88. PubMed ID: 16421164
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.
Sage EH; Bassuk JA; Yost JC; Folkman MJ; Lane TF
J Cell Biochem; 1995 Jan; 57(1):127-40. PubMed ID: 7721952
[TBL] [Abstract][Full Text] [Related]
14. Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.
Chang CH; Yen MC; Liao SH; Hsu YL; Lai CS; Chang KP; Hsu YL
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718842
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition.
Dhanesuan N; Sharp JA; Blick T; Price JT; Thompson EW
Breast Cancer Res Treat; 2002 Sep; 75(1):73-85. PubMed ID: 12500936
[TBL] [Abstract][Full Text] [Related]
16. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
Basu A; Rodeck U; Prendergast GC; Howe CC
Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
[TBL] [Abstract][Full Text] [Related]
17. Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation.
Shi Q; Bao S; Maxwell JA; Reese ED; Friedman HS; Bigner DD; Wang XF; Rich JN
J Biol Chem; 2004 Dec; 279(50):52200-9. PubMed ID: 15469933
[TBL] [Abstract][Full Text] [Related]
18. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
[TBL] [Abstract][Full Text] [Related]
19. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
Francki A; Motamed K; McClure TD; Kaya M; Murri C; Blake DJ; Carbon JG; Sage EH
J Cell Biochem; 2003 Mar; 88(4):802-11. PubMed ID: 12577314
[TBL] [Abstract][Full Text] [Related]
20. The expression, regulation and function of secreted protein, acidic, cysteine-rich in the follicle-luteal transition.
Joseph C; Hunter MG; Sinclair KD; Robinson RS
Reproduction; 2012 Sep; 144(3):361-72. PubMed ID: 22733805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
